American Association of Hip and Knee Surgeons

Advocacy, Education, Research

2013 Annual Meeting Abstracts

Podium Presentation Abstracts

James A. Rand Award

Barbed vs. Standard Sutures for Closure in Total Knee Arthroplasty: A Multicenter Prospective Randomized Trial. Jeremy M. Gililland, MD, et al.

Lawrence D. Dorr Award

Do You Have to Remove a Corroded Femoral Stem? Nitin Goyal, MD, et al.

AAHKS Clinical Research Award

Can the Average Total Joint Orthopaedic Surgeon Maintain an Average Income at Medicare Reimbursement Rates? Richard Iorio, MD, et al.

Abstracts in Numeric Order
  1. Economic Benefit to the Society at Large of TKA in the Young Patient: A Markov Analysis. Hany S. Bedair, MD, et al.
  2. Younger Age is Associated with a Higher Risk of Periprosthetic Infection and Aseptic Failure after Total Knee Arthroplasty. John P. Meehan, MD, et al.
  3. Perioperative Morbidity and Mortality of Same Admission Staged Bilateral Total Knee Arthroplasty. Lazaros A. Poultsides, MD, MSc, PhD, et al.
  4. Rheumatoid Arthritis Does Not Increase Perioperative Complications Following Same-Day Bilateral Total Knee Arthroplasty. Mark Figgie, MD, et al.
  5. Particles from Vitamin-E-Diffused HXL UHMWPE Induce Less Osteolysis Compared to Virgin HXL UHMWPE in a Murine Calvarial Bone Model. Orhun K. Muratoglu, PhD, et al.
  6. At 5 Years Highly-Porous-Metal Tibial Components Were Durable and Reliable: A Randomized Clinical Trial of 389 Patients. Luis F. Pulido Sierra, MD, et al.
  7. Correlation of Patient Confidence in Attaining Treatment Goals and Outcomes after Knee Arthroplasty. Joseph F. Styron, MD, PhD, et al.
  8. Variations in Hospital Billing for Total Joint Arthroplasty. Louis S. Stryker, MD, et al.
  9. Patients’ Willingness to Contribute to Cost of Novel Implants in Total Joint Arthroplasty. Ran Schwarzkopf, MD, MSc, et al.
  10. Medicare Fails to Compensate the Additional Time and Effort Associated with Revision Arthroplasty: Is Patient Access to Care at Risk? Gregory K. Deirmengian, MD, et al.
  11. Prevalence of Radiographic Abnormalities in Senior Athletes With Well-Functioning Hips. Lucas A. Anderson, MD, et al.
  12. Periacetabular Osteotomy for Acetabular Dysplasia: Are Male Patients at Higher Risk for Secondary Femoroacetabular Impingement? Stephen T. Duncan, MD, et al.
  13. Genome-Wide Linkage Analysis and Whole Exome Sequencing in a Large Multi-Generation Family Reveal Deleterious Mutations in Severely Affected Individuals with Developmental Dysplasia of the Hip. George Feldman, PhD, DMD, et al.
  14. Periacetabular Osteotomy after Failed Treatment with Hip Arthroscopy. John C. Clohisy, MD, et al.
  15. Weighted versus Uniform Dose of Tranexamic Acid in Patients Undergoing Primary, Elective Knee Arthroplasty: A Prospective Randomized Controlled Trial. Brett Levine, MD, MS, et al.
  16. Prospective Randomized Trial Comparing Peripheral Nerve Blocks and Periarticular Injection for Pain Management after Total Knee Replacement. Mark J. Spangehl, MD, et al.
  17. A Comparison of Continuous Femoral Nerve Catheter versus Adductor Canal Block for Postoperative Pain Management Following Total Knee Arthroplasty. Lalit Puri, MD, MBA, et al.
  18. Transfer of Hip Arthroplasty Patients Leads to Increased Cost and Resource Utilization in the Receiving Hospital. Atul F. Kamath, MD, et al.
  19. Are Patient Reported Allergies a Risk Factor for Poor Outcomes in Total Hip and Knee Arthroplasty? Christopher M. Graves, MD, et al.
  20. Predictors and Complications of Blood Transfusion in Total Hip and Knee Arthroplasty. Nicholas B. Frisch, MD, MBA, et al.
  21. Posterior Stabilized versus Cruciate-Substituting Total Knee Arthroplasty: Midterm Results. David F. Scott, MD.
  22. Radiographic and Technical Factors Associated with Patellar Clunk Syndrome following Posterior Stabilized Total Knee Arthroplasty. James J. Purtill, MD, et al.
  23. Current Data does not Support Routine use of Patient-Specific Instrumentation in Total Knee Arthroplasty. Pramod B. Voleti, MD, et al.
  24. Oxford Phase III Medial Unicompartmental Knee Arthroplasty (UKA) Results of 497 Knees with a Mean 5-year follow-up and Analysis of Predictors of Failure. Stephen Burnett, MD, FRCSC, et al.
  25. Differences in Short Term Complications Between Unicompartmental and Total Knee Arthroplasty: A Propensity Score Matched Analysis. John J. Callaghan, MD, et al.
  26. Revising an HTO or UKA to TKA: Is It More Like a Primary TKA or a Revision TKA? Michael B. Cross, MD, et al.
  27. Trends in Total Hip Arthroplasty in the United States: The Shift to a Younger Demographic. Jacob M. Drew, MD, et al.
  28. Pain Patterns in Young, Active Patients following Hip Arthroplasty. Ryan M. Nunley, MD, et al.
  29. Assessment of Durability and Function at Minimum 35 Year follow-up of THA in Patients 50 and Under. Lucian C. Warth, MD, et al.
  30. Performance of Highly Cross-Linked Polyethylene in Total Hip Arthroplasty in Young and Active Patients. Morteza Meftah, MD, et al.
  31. Stress and Strain in the Trunnion with Big Heads: Tribocorrosion Turbocharged. Carlos J. Lavernia, MD, FAAOS, et al.
  32. Direct Anterior versus Mini-Posterior Total Hip Arthroplasty with the Same Advanced Pain Management and Rapid Rehabilitation Protocol: Some Surprises in Early Outcome. Kirsten Poehling Monaghan, MD, et al.
  33. Direct Anterior Hip Yields Faster Voluntary Cessation of All Walking Aids in a Randomized Trial. Michael J. Taunton, MD, et al.
  34. Mechanically Assisted Taper Corrosion in Modular TKA. Christina M. Arnholt, BS, et al.
  35. Stepped Porous Titanium Metaphyseal Sleeves for Tibial Defects in Revision Total Knee Arthroplasty. Joseph S. Gondusky, MD, et al.
  36. Early Clinical Results of Mobile Bearing Revision TKA: A Multicenter Study. Douglas A. Dennis, MD, et al.
  37. Clinical & Radiographic Outcomes of Cemented vs. Diaphyseal Engaging Cementless Stems in Aseptic Revision TKA. Walter B. Beaver, MD, et al.
  38. Decreased Blood Transfusions following Revision Total Knee Arthroplasty using Tranexamic Acid. Christopher A. Samujh, MD, et al.
  39. Aspirin May be Adequate for Prevention of Thromboembolic Events following Revision Total Joint Arthroplasty. Javad Parvizi, MD, FRCS, et al.
  40. Positive Culture from the Liquid Medium Only after Total Joint Arthroplasty: Is it Reliable? Eric B. Smith, MD, et al.
  41. Diagnosing Periprosthetic Joint Infection: The Era of the Biomarker Has Arrived. Carl A. Deirmengian, MD, et al.
  42. The Host Response: Toll Like Receptor Expression in Periprosthetic Tissues as a Biomarker for Deep Joint Infection. Cara A. Cipriano, MD, et al.
  43. Prospective, Randomized, Blinded Study to Evaluate the Efficacy of Two Surgical Skin Preparations in Reducing SSI after TJA. Richard H. Rothman, MD, PhD, et al.
  44. Public Reporting of Prosthetic Joint Infections: Do Claims Based Comorbidities Adequately Capture Case-Mix? Hilal Maradit-Kremers, MD, MSc, et al.
  45. Comparison of a Clinically-Derived Prosthetic Joint Infection (PJI) Risk Model and the NHSN Risk Model. Tad M. Mabry, MD, et al.
  46. Risk Factors for Infection after Hip Arthroplasty: Preventable vs. Non-Preventable Infection. James D. Slover, MD, et al.
  47. Reproducible Fixation with a Modular, Fluted, Tapered Titanium Stem in Revision Hip Arthroplasty At 8-13 Years Follow-up. Jose A. Rodriguez, MD, et al.
  48. Outcomes of Revision Total Hip Arthroplasty: Analysis of a US based Total Joint Replacement Registry. Stefano A. Bini, MD, et al.
  49. Revision THA in Obese Patients Is Associated with High Reoperation Rates at Short Term follow Up. Michael H. McGraw, MD, et al.
  50. Outcomes after Revision of Metal-on-Metal Hip Resurfacing Arthroplasty. Thomas P. Gross, MD, et al.
  51. Predictive Demographic and Comorbid Factors on Functional Outcomes following Revision Hip Arthroplasty. Ivan M. Tomek, MD, FRCSC, et al.
  52. Construct Rigidity: Keystone for Reconstructing Pelvic Discontinuity. J. Ryan Martin, MD, et al.
  53. How Does Acetabular Component Orientation Change from Supine to Standing in Patients with Total Hip Arthroplasty? John V. Tiberi, MD, et al.
  54. Adverse Clinical Outcomes in a Primary Modular Neck/Stem System. Camilo Restrepo, MD, et al.
  55. 10 Year follow-up of Highly Cross-Linked Polyethylene using Radiostereometric Analysis (RSA). Henrik Malchau, MD, PhD, et al.
  56. A Randomized Controlled Trial Comparing Wear of Oxinium and Cobalt-Chrome on Standard and Cross-Linked Polyethylene.James P. Waddell, MD, et al.
  57. 3 Year Multicenter RSA Evaluation of Vitamin E Diffused Highly Cross-Linked Polyethylene Liners and Acetabular Cup Stability. Nanna H. Sillesen, MD, et al.
  58. Stratification of Total Hip Arthroplasty Survival according to BMI as a Continuous Variable. Eric R. Wagner, MD, et al.
  59. Percent Body Fat More Associated with Perioperative Outcomes after Total Joint Arthroplasty than BMI. K. Ledford, MD, et al.